A Study of MHB046C Injection in Patients With Advanced Solid Tumors

Summary

This is a first-in-human, open-label, multicenter Phase I/II study of MHB046C in patients with advanced solid tumors. The study was designed to evaluate the safety, tolerability, pharmacokinetics (PK), and preliminary efficacy of MHB046C monotherapy.

Timeline

Start

2025-07-17

Primary completion

2029-05

Completion

2031-05

Drugs

Indications